Quest diagnostics granted fda breakthrough designation for its adeno-associated virus (aav) test

Quest and sarepta therapeutics expand collaboration to develop aav companion diagnostics (cdx) for sarepta's gene therapies secaucus, n.j. and cambridge, mass.

DGX Ratings Summary

DGX Quant Ranking